Correlation Between Dermata Therapeutics and Hillstream Biopharma
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Hillstream Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Hillstream Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Hillstream Biopharma, you can compare the effects of market volatilities on Dermata Therapeutics and Hillstream Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Hillstream Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Hillstream Biopharma.
Diversification Opportunities for Dermata Therapeutics and Hillstream Biopharma
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Dermata and Hillstream is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Hillstream Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hillstream Biopharma and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Hillstream Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hillstream Biopharma has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Hillstream Biopharma go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and Hillstream Biopharma
Given the investment horizon of 90 days Dermata Therapeutics is expected to under-perform the Hillstream Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Dermata Therapeutics is 1.16 times less risky than Hillstream Biopharma. The stock trades about -0.03 of its potential returns per unit of risk. The Hillstream Biopharma is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 44.00 in Hillstream Biopharma on August 29, 2024 and sell it today you would lose (5.00) from holding Hillstream Biopharma or give up 11.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 31.25% |
| Values | Daily Returns |
Dermata Therapeutics vs. Hillstream Biopharma
Performance |
| Timeline |
| Dermata Therapeutics |
| Hillstream Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Dermata Therapeutics and Hillstream Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and Hillstream Biopharma
The main advantage of trading using opposite Dermata Therapeutics and Hillstream Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Hillstream Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hillstream Biopharma will offset losses from the drop in Hillstream Biopharma's long position.| Dermata Therapeutics vs. Zura Bio Limited | Dermata Therapeutics vs. Phio Pharmaceuticals Corp | Dermata Therapeutics vs. Sonnet Biotherapeutics Holdings | Dermata Therapeutics vs. 180 Life Sciences |
| Hillstream Biopharma vs. Virax Biolabs Group | Hillstream Biopharma vs. Revelation Biosciences | Hillstream Biopharma vs. Kiora Pharmaceuticals | Hillstream Biopharma vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |